SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-009201
Filing Date
2018-05-09
Accepted
2018-05-09 16:02:01
Documents
65
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prog20180331_10q.htm 10-Q 846570
2 EXHIBIT 31.1 ex_112691.htm EX-31.1 11998
3 EXHIBIT 31.2 ex_112692.htm EX-31.2 12042
4 EXHIBIT 32 ex_112693.htm EX-32 7866
  Complete submission text file 0001437749-18-009201.txt   4998396

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pgnx-20180331.xml EX-101.INS 1173490
6 XBRL TAXONOMY EXTENSION SCHEMA pgnx-20180331.xsd EX-101.SCH 52730
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pgnx-20180331_cal.xml EX-101.CAL 38265
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pgnx-20180331_def.xml EX-101.DEF 310192
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pgnx-20180331_lab.xml EX-101.LAB 287365
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pgnx-20180331_pre.xml EX-101.PRE 343179
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Filer) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23143 | Film No.: 18818194
SIC: 2834 Pharmaceutical Preparations